The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 25, 2025

Filed:

Feb. 08, 2024
Applicant:

Insulet Corporation, Acton, MA (US);

Inventors:

Joon Bok Lee, Acton, MA (US);

Mengdi Li, Westford, MA (US);

Jason O'Connor, Acton, MA (US);

Yibin Zheng, Hartland, WI (US);

Assignee:

INSULET CORPORATION, Acton, MA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G08B 1/08 (2006.01); A61M 5/172 (2006.01); G16H 10/40 (2018.01); G16H 10/60 (2018.01); G16H 20/17 (2018.01); G16H 40/60 (2018.01); G16H 40/67 (2018.01); G16H 50/20 (2018.01); G16H 50/30 (2018.01); G16H 50/50 (2018.01); G16H 50/70 (2018.01); H04L 67/141 (2022.01);
U.S. Cl.
CPC ...
A61M 5/1723 (2013.01); G16H 10/40 (2018.01); G16H 10/60 (2018.01); G16H 20/17 (2018.01); G16H 40/60 (2018.01); G16H 40/67 (2018.01); G16H 50/20 (2018.01); G16H 50/30 (2018.01); G16H 50/50 (2018.01); G16H 50/70 (2018.01); A61M 2202/07 (2013.01); A61M 2205/3584 (2013.01); A61M 2205/50 (2013.01); A61M 2205/502 (2013.01); A61M 2230/20 (2013.01); A61M 2230/201 (2013.01); H04L 67/141 (2013.01);
Abstract

Disclosed are techniques to establish initial settings for an automatic insulin delivery device. An adjusted total daily insulin (TDI) factor usable to calculate a TDI dosage may be determined. The adjusted TDI factor may be a TDI per unit of a physical characteristic of the user (e.g., weight) times a reduction factor. The adjusted TDI factor may be compared to a maximum algorithm delivery threshold. Based on the comparison result, the application or algorithm may set a TDI dosage and output a control signal. Blood glucose measurement values may be collected from a sensor over a period of time. A level of glycated hemoglobin of the blood may be determined based on the obtained blood glucose measurement values. In response to the level of glycated hemoglobin, the set TDI dosage may be modified. A subsequent control signal including the modified TDI dosage may be output to actuate delivery of insulin.


Find Patent Forward Citations

Loading…